搜索筛选:
搜索耗时1.0875秒,为你在为你在102,285,761篇论文里面共找到 5 篇相符的论文内容
发布年度:
Exogenous MUC1 tandem repeat peptide inhibit growth of tumor cells by binding a novel Samll MUC1 pro
[会议论文] 作者：Jichun Ma,Guixiang Tai,Fang Fang,Xiaoxia Zhao,Qingyong Zhang,Rui Dou,Wenbo Chen,Xushou Li,Tong Chen,Zhonghui,
来源：2009年亚太地区肿瘤生物学和医学学术会议暨第四届中国中青年肿瘤专家论坛 年份：2009
...
Exogenous MUC1 tandem repeat peptide inhibit growth of tumor cells by binding a novel Samll MUC1 pro
[会议论文] 作者：Jichun Ma,Guixiang Tai,Fang Fang,Xiaoxia Zhao,Qingyong Zhang,Rui Dou,Wenbo Chen,Xushou Li,Tong Chen,Zhonghui,
来源：2009年亚太地区肿瘤生物学和医学学术会议暨第四届中国中青年肿瘤专家论坛 年份：2009
...
MiR-378 promoted cell proliferation and inhibited apoptosis by enhanced stem cell properties in chro
[会议论文] 作者：Jichun Ma,Dehong Wu,Jing Yi,Yunyun Yi,Xin Zhu,Hongchun Qiu,Rong Kong,Jiang Lin,Jun Qian,Zhaoqun Deng,
来源：2019中国肿瘤学大会 年份：2019
Objective Chronic myeloid leukemia(CML)is a clonal myeloproliferative disorder characterized by overproduction of myeloid cells in bone marrow,peripheral blood as well as extramedullary tissue....
DOK6 promoter methylation serves as an independent prognostic biomarker in de novo acute myeloid leu
[会议论文] 作者：guokang sun,Lijuan Tang,Jingdong Zhou,Zijun Xu,Lan Yang,Qian Yuan,Jichun Ma,Xinghui Liu,Jiang Lin,Jun,
来源：2019中国肿瘤学大会 年份：2019
Objective AML is a heterogeneous group of clonal hematopoietic stem-cell disorders that is now cured in 35 to 40%of adult patients who are younger than 60 years of age and in 5 to 15%of patients who a...
Down-regulation of miR-29c is a prognostic biomarker in acute myeloid leukemia and can reduce the se
[会议论文] 作者：Tingjuan Zhang,Dehong Wu,Jingdong Zhou,Beibei Ma,Zijun Xu,Xiangmei Wen,Qin Chen,Dongmin Yao,Jun Qian,Jichun Ma,
来源：2019中国肿瘤学大会 年份：2019
Objective Acute myeloid leukemia(AML)is a malignant tumor of myeloid progenitor cells.It is characterized by the rapid growth of abnormal white blood cells in the bone marrow,which interferes with the...
相关搜索：
